UTHR logo

United Therapeutics Corporation (UTHR)

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultraso...

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUSA

Company Profile

Stock Code
UTHR
ISIN Code
US91307C1027
Currency
US Dollar (USD)
IPO Date
1999-06-17

Contact Information

Company Address
1000 Spring Street, Silver Spring, MD, United States, 20910
Contact Phone
301 608 9292
Company Website
https://www.unither.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Return on Assets (TTM)
12.62%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99